HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters.

Abstract
Previous studies tested the efficacy of sertraline in Binge Eating Disorder (BED) over a period of 6 weeks. The present open study assesses the efficacy of sertraline over a period of 24 weeks in obese persons with binge eating behaviour (with or without the full criteria for BED) confirmed by high scores on the Binge Eating Scale (BES). Thirty-two obese outpatients (14 with BED and 18 without full criteria for BED), without co-occurring psychiatric comorbidities, were treated with sertraline (dose range 100-200 mg/d). Subjects were assessed at baseline and at 8, 12 and 24 weeks of treatment for number of binges, weight and psychopathology. After 8 weeks of treatment a significant improvement in the BES score and a significant weight loss emerged. These results were maintained over 24 weeks. A moderate drop out rate was detected, but no significant association with the severity of side effects was found. Further studies are needed to confirm the usefulness of sertraline in the treatment of patients with BED and also in binge eaters with a less severe eating psychopathology.
AuthorsPaolo Leombruni, Andrea Pierò, Annalisa Brustolin, Valeria Mondelli, Maura Levi, Stefania Campisi, Susanna Marozio, Giovanni Abbate-Daga, Secondo Fassino
JournalHuman psychopharmacology (Hum Psychopharmacol) Vol. 21 Issue 3 Pg. 181-8 (Apr 2006) ISSN: 0885-6222 [Print] England
PMID16625525 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
CopyrightCopyright (c) 2006 John Wiley & Sons, Ltd.
Chemical References
  • Serotonin Uptake Inhibitors
  • Sertraline
Topics
  • Adolescent
  • Adult
  • Aged
  • Analysis of Variance
  • Body Mass Index
  • Body Weight (drug effects)
  • Bulimia Nervosa (complications, drug therapy, mortality)
  • Female
  • Humans
  • Middle Aged
  • Obesity (complications, drug therapy, mortality, psychology)
  • Personality Inventory (statistics & numerical data)
  • Pilot Projects
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Sertraline (therapeutic use)
  • Severity of Illness Index
  • Survival Analysis
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: